Curaleaf Holdings (CURLF) Net Income towards Common Stockholders (2019 - 2026)

Curaleaf Holdings (CURLF) recorded quarterly Net Income towards Common Stockholders of -$293000.0 in Q1 2026, up 100.0% quarter-over-quarter from -$8.3 billion in Q4 2025, and up 97.13% on a YoY basis from -$148636.3 in Q1 2025.

Curaleaf Holdings (CURLF) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends

Curaleaf Holdings' Net Income towards Common Stockholders history runs 8 years deep, the most recent figure standing at -$293000.0 for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 97.13% year-over-year to -$293000.0; the TTM figure through Mar 2026 stood at -$11.3 billion (down 53224.66% YoY), while the FY2025 annual figure was -$26.2 million, down 152.45% from the prior year.
  • Net Income towards Common Stockholders was -$293000.0 for Q1 2026 at Curaleaf Holdings, up from -$8.3 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $21.4 million in Q1 2022 to a low of -$8.3 billion in Q4 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$1.1 billion across 5 years, with a median of -$10.2 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders soared 106.25% in 2024, then plunged 235138.84% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$86.4 million in 2022, then slumped by 9157.22% to -$8.0 billion in 2023, then soared by 99.86% to -$11.3 million in 2024, then plunged by 73087.12% to -$8.3 billion in 2025, then jumped by 100.0% to -$293000.0 in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$293000.0 (Q1 2026), -$8.3 billion (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 Curaleaf Holdings - - 157.29 Mn -293,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -293,000.00
Dec 31, 2025 -8.28 Bn
Sep 30, 2025 -2.14 Mn
Jun 30, 2025 -3.00 Bn
Mar 31, 2025 -10.19 Mn
Dec 31, 2024 -11.31 Mn
Sep 30, 2024 1.62 Mn
Jun 30, 2024 -1.28 Mn
Mar 31, 2024 567,000.00
Dec 31, 2023 -8.00 Bn
Sep 30, 2023 -25.92 Mn
Jun 30, 2023 -7.90 Mn
Mar 31, 2023 -12.59 Mn
Dec 31, 2022 -86.37 Mn
Sep 30, 2022 -12.73 Mn
Jun 30, 2022 -4.50 Mn
Mar 31, 2022 21.39 Mn
Dec 31, 2021 -5.24 Mn
Sep 30, 2021 62.95 Mn
Jun 30, 2021 76.97 Mn